查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1944417

全球薦椎神經刺激療法市場：產業分析、市場規模、佔有率及2025-2032年預測（依產品類型、應用、最終用戶、患者年齡層、技術、國家及地區分類）

Sacral Neuromodulation Market, By Product Type, By Application, By End User, By Patient Age Group, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 374 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年薦椎神經刺激市場規模價值19.8787億美元，從2025年到2032年以11.51%的複合年成長率成長。

薦椎神經刺激（SNM）是一種利用電脈衝刺激薦骨神經的醫療治療方法。該治療方法透過糾正骨盆器官與大腦之間異常的神經訊號來恢復正常的神經功能。醫生通常對膀胱過動症過動症、急性尿失禁和糞便失禁等症狀，以及對行為療法和藥物治療等標準療法無效的患者採用薦椎神經刺激刺激術。治療首先進行試驗階段，在此期間，醫生會監測患者對測試性刺激的反應。症狀顯著緩解的患者隨後會被植入永久性神經刺激設備。

薦椎神經刺激市場動態

提高公眾意識和改善報銷途徑

薦椎神經刺激市場成長主要歸功於兩大因素：一是醫患教育水平的提高，使得膀胱和腸道疾病的診斷和神經調控療法得以更早地被接受；二是臨床培訓項目的拓展、臨床證據的強化以及薦椎神經刺激療法被納入泌尿系統和胃腸病學治療指南，這些因素共同提升了醫生的信心和轉診率三三是北美認知度的提高和報銷體系的完善，改善了患者獲得治療的機會，加速了薦椎神經刺激療法作為難治性疾病標準療法的普及，並推動了市場的持續成長。

薦椎神經刺激刺激市場：細分分析

依產品類型

預計在預測期內，植入式脈衝產生器 (IPG) 細分市場將主導市場。薦椎神經刺激刺激系統依賴 IPG 直接連接薦骨神經，輸送可控電脈衝，從而治療骨盆底功能障礙。 IPG 設備是治療操作的關鍵組成部分，直接推動了市場需求與薦椎神經刺激療法的普及應用，並為整個行業帶來了可觀的收入。小型化設計、長電池壽命、MRI 相容性和可編程性等技術進步，使 IPG 對患者和醫生都更加有益。這些改進轉化為更高的患者舒適度和更佳的臨床療效，從而提高了產品的使用率和重購率。

薦椎神經刺激刺激市場—區域分析

預計北美將在預測期內引領薦椎神經刺激市場。成長的主要驅動力是骨盆底功能障礙（包括尿失禁和糞便失禁）的高發生率，這導致對有效神經調控治療的持續需求。該地區擁有完善的醫療保健網路，多家醫療機構提供基於成熟臨床實踐的先進治療方案，例如薦椎神經刺激療法。美國和加拿大目前正在推行更完善的報銷政策和更廣的保險覆蓋範圍，降低了患者和醫療機構面臨的經濟負擔，從而提高了薦椎神經刺激療法的可及性和經濟可行性。主要醫療設備製造商的存在以及神經調控系統技術的不斷進步，促成了具有更長電池壽命和更高級可編程性的優質植入式設備的開發。這提高了醫生和患者的接受度，從而推動了北美市場的收入成長。

目錄

第1章 薦薦椎神經刺激市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 薦薦椎神經刺激療法的主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章薦椎神經刺激市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章薦椎神經刺激市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 薦薦椎神經刺激市場現狀

  • 薦椎神經刺激市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 薦薦椎神經刺激刺激市場（依產品類型分類）

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 體外/非植入式脈衝產生器（EPG）
    • 鉛電極
    • 植入式脈衝產生器（IPG）
    • 附件和系統元件

第8章薦椎神經刺激市場依應用領域分類

  • 概述
    • 細分市場佔有率分析：按應用
    • 尿失禁
    • 閉尿症
    • 大便失禁
    • 膀胱過動症
    • 慢性及相關骨盆腔疼痛
    • 其他

第9章薦椎神經刺激療法市場（按最終用戶分類）

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院及大型醫療中心
    • 門診手術中心
    • 專科診所
    • 研究和學術機構

第10章 依患者年齡層分類的薦椎神經刺激療法市場

  • 概述
    • 細分市場佔有率分析：依患者年齡層別分類
    • 成人
    • 兒童
    • 老年人

第11章薦椎神經刺激市場（依技術分類）

  • 概述
    • 細分市場佔有率分析：依技術分類
    • 可充電系統
    • 不可充電系統
    • 有線/引線系統與無線/無引線系統
    • 試驗系統與永久系統的比較

第12章薦椎神經刺激市場（按地區分類）

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第13章 主要供應商分析－薦椎神經刺激產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • BioControl Medical
    • Uroplasty Inc.
    • Cogentix Medical Inc.
    • Cyberonics Inc.
    • Nuvectra Corporation
    • Nevro Corp.
    • Synapse Biomedical Inc.
    • ImThera Medical Inc.
    • Abbott Laboratories
    • Advanced Bionics AG
    • Stryker Corporation
    • Inspire Medical Systems Inc.
    • Laborie Medical Technologies
    • MicroTransponder Inc.
    • Brainsway Ltd.
    • EndoStim Inc.
    • Stimwave LLC

第14章：分析師視角360度分析

簡介目錄
Product Code: ANV5985

Sacral Neuromodulation market size was valued at US$ 1,987.87 Million in 2024, expanding at a CAGR of 11.51% from 2025 to 2032.

Sacral neuromodulation (SNM) works as a medical treatment that uses electrical pulses to stimulate sacral nerves. The treatment restores normal nerve function by treating abnormal nerve signals that exist between the pelvic organs and the brain. Doctors use sacral neuromodulation to treat patients who suffer from overactive bladder and urinary urge incontinence, non-obstructive urinary retention, and fecal incontinence when patients do not respond to standard treatments, which include behavioral therapy and medications. The procedure starts with a testing phase, which monitors patient response through test stimulation, before doctors implant a permanent neurostimulator system in patients who demonstrate substantial symptom relief.

Sacral Neuromodulation Market- Market Dynamics

Increased awareness and improved reimbursement pathways

The sacral neuromodulation market experiences growth because two main factors drive its expansion, since better physician and patient education result in earlier diagnosis and increased acceptance of neuromodulation therapies to treat bladder and bowel disorders. The combinationof expanded clinical training programs with stronger clinical evidence and the inclusion of sacral neuromodulation in urology and gastroenterology treatment guidelines has increased physician confidence and referral rates. The combination of clear reimbursement frameworks with expanded insurance coverage in North America and selected European markets has decreased the financial expenses that patients need to pay for device implantation and subsequent treatment. The combination of enhanced awareness with better reimbursement systems has improved patient access to treatment, which results in faster adoption of sacral neuromodulation as standard therapy for refractory conditions and drives ongoing market growth.

Sacral Neuromodulation Market- Segmentation Analysis:

By Product Type

The Implantable Pulse Generators (IPGs) segment is expected to dominate the market over the forecast period. Sacral neuromodulation systems depend on IPGs which provide controlled electrical pulses that treat pelvic floor disorders through their direct connection to sacral nerves. The IPG devices serve as essential components for therapy operations which creates a direct link between their market demand and the adoption of sacral neuromodulation treatments that generate substantial revenue in the entire industry market. The ongoing development of technology through smaller device designs, extended battery operation, MRI compatibility, and programmable capabilities has made IPGs more beneficial for patients and doctors. The improvements lead to better patient comfort, which results in better clinical outcomes, and this effect increases both usage rates and product repurchases.

Sacral Neuromodulation Market- Geographical Insights

North America is expected to dominate the Sacral Neuromodulation market during the forecast period. The main reason for growth comes from the high occurrence of urinary and fecal incontinence, together with other pelvic floor disorders, which create a continuous need for effective neuromodulation treatments. The region enjoys benefits from its strong healthcare network, which provides multiple medical facilities that offer advanced treatment options and operate under established clinical methods for treating patients through procedures like sacral nerve stimulation. The United States and Canada now provide better reimbursement systems together with expanded insurance coverage, which reduces financial barriers that patients and healthcare facilities face, thereby increasing the availability and economic feasibility of sacral neuromodulation as a treatment option. The presence of major device manufacturers together with ongoing technological advancements in neuromodulation systems has led to the creation of better implantable devices that feature extended battery life and advanced programming functions, which help doctors choose these devices while patients become more willing to accept them, thus driving revenue growth in the North American market.

Sacral Neuromodulation Market- Competitive Landscape:

The sacral neuromodulation market functions through intense competition, which three major medtech companies Medtronic Axonics and Boston Scientific control while other established companies, including Abbott and various regional device manufacturers, compete. The market competition arises through three main factors which include technology differences that involve smaller MRI-safe rechargeable-free implantable pulse generators, better leads and programming software and the strength of distribution and clinical support, which helps doctors adopt new technologies. The current market environment results from legal and IP contests that have occurred between companies, while recent court decisions and active disputes have changed market competition and access. The market distribution keeps changing through ongoing product approvals, targeted M&A activities and strategic partnerships, while fast-growing Asian markets have become accessible for both agile competitors and local businesses to operate.

Recent Developments:

In June 2025, Neuspera(R) Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system for the treatment of urinary urge incontinence (UUI).

In May 2025, Medtronic launched its next-generation InterStim X system featuring advanced wireless programming capabilities and extended battery life, significantly improving patient convenience and treatment outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SACRAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BioControl Medical
  • Uroplasty Inc.
  • Cogentix Medical Inc.
  • Cyberonics Inc.
  • Nuvectra Corporation
  • Nevro Corp.
  • Synapse Biomedical Inc.
  • ImThera Medical Inc.
  • Abbott Laboratories
  • Advanced Bionics AG
  • Stryker Corporation
  • Inspire Medical Systems Inc.
  • Laborie Medical Technologies
  • MicroTransponder Inc.
  • Brainsway Ltd.
  • EndoStim Inc.
  • Stimwave LLC

GLOBAL SACRAL NEUROMODULATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • External/Non-Implantable Pulse Generators (EPGs)
  • Lead Electrodes
  • Implantable Pulse Generators (IPGs)
  • Accessories and System Components

GLOBAL SACRAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Urinary Incontinence
  • Urinary Retention
  • Fecal Incontinence
  • Overactive Bladder
  • Chronic Pelvic Pain and Relative Pelvic Pain
  • Others

GLOBAL SACRAL NEUROMODULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Large Medical Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research and Academic Institutes

GLOBAL SACRAL NEUROMODULATION MARKET, BY PATIENT AGE GROUP- MARKET ANALYSIS, 2019 - 2032

  • Adult
  • Pediatric
  • Geriatric

GLOBAL SACRAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Rechargeable Systems
  • Non-Rechargeable Systems
  • Wired/Lead Systems vs Wireless/Leadless Systems
  • Trial Systems vs Permanent Systems

GLOBAL SACRAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sacral Neuromodulation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sacral Neuromodulation Market Snippet by Product Type
    • 2.1.2. Sacral Neuromodulation Market Snippet by Application
    • 2.1.3. Sacral Neuromodulation Market Snippet by End User
    • 2.1.4. Sacral Neuromodulation Market Snippet by Patient Age Group
    • 2.1.5. Sacral Neuromodulation Market Snippet by Technology
    • 2.1.6. Sacral Neuromodulation Market Snippet by Country
    • 2.1.7. Sacral Neuromodulation Market Snippet by Region
  • 2.2. Competitive Insights

3. Sacral Neuromodulation Key Market Trends

  • 3.1. Sacral Neuromodulation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sacral Neuromodulation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sacral Neuromodulation Market Opportunities
  • 3.4. Sacral Neuromodulation Market Future Trends

4. Sacral Neuromodulation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sacral Neuromodulation Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Sacral Neuromodulation Market Landscape

  • 6.1. Sacral Neuromodulation Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sacral Neuromodulation Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. External/Non-Implantable Pulse Generators (EPGs)
    • 7.1.3. Lead Electrodes
    • 7.1.4. Implantable Pulse Generators (IPGs)
    • 7.1.5. Accessories and System Components

8. Sacral Neuromodulation Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Urinary Incontinence
    • 8.1.3. Urinary Retention
    • 8.1.4. Fecal Incontinence
    • 8.1.5. Overactive Bladder
    • 8.1.6. Chronic Pelvic Pain and Relative Pelvic Pain
    • 8.1.7. Others

9. Sacral Neuromodulation Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals and Large Medical Centers
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics
    • 9.1.5. Research and Academic Institutes

10. Sacral Neuromodulation Market - By Patient Age Group

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Patient Age Group, 2024 & 2032 (%)
    • 10.1.2. Adult
    • 10.1.3. Pediatric
    • 10.1.4. Geriatric

11. Sacral Neuromodulation Market - By Technology

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 11.1.2. Rechargeable Systems
    • 11.1.3. Non-Rechargeable Systems
    • 11.1.4. Wired/Lead Systems vs Wireless/Leadless Systems
    • 11.1.5. Trial Systems vs Permanent Systems

12. Sacral Neuromodulation Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Sacral Neuromodulation Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Sacral Neuromodulation Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Sacral Neuromodulation Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Sacral Neuromodulation Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Sacral Neuromodulation Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Sacral Neuromodulation Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. BioControl Medical
    • 13.2.2. Uroplasty Inc.
    • 13.2.3. Cogentix Medical Inc.
    • 13.2.4. Cyberonics Inc.
    • 13.2.5. Nuvectra Corporation
    • 13.2.6. Nevro Corp.
    • 13.2.7. Synapse Biomedical Inc.
    • 13.2.8. ImThera Medical Inc.
    • 13.2.9. Abbott Laboratories
    • 13.2.10. Advanced Bionics AG
    • 13.2.11. Stryker Corporation
    • 13.2.12. Inspire Medical Systems Inc.
    • 13.2.13. Laborie Medical Technologies
    • 13.2.14. MicroTransponder Inc.
    • 13.2.15. Brainsway Ltd.
    • 13.2.16. EndoStim Inc.
    • 13.2.17. Stimwave LLC

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us